In this study, we try to evidence that IL-6 gene expression is upregulated in MS obtained from aggressive ductal breast carcinomas and that IL-6 regulates a Notch-3-dependent signaling pathway that promotes self-renewal and the invasive potentials of normal and tumor MS. This evidence concerns the gene NOTCH3 and breast ductal adenocarcinoma.